iRhythm Technologies Inc. (IRTC) saw its stock price soar 7.02% during intraday trading on Thursday, following the release of its first-quarter financial results.
The medical technology company reported Q1 2026 revenue of $199.4 million, surpassing the IBES estimate of $194 million. This positive earnings surprise appears to be the primary driver behind the significant share price increase.
Additionally, the company reported a strong gross margin of 70.9% and a gross profit of $141.4 million for the quarter. While iRhythm Technologies reported a net loss for the period, the better-than-expected top-line performance has fueled investor optimism.
Comments